Rigel Pharmaceuticals (RIGL) Change in Account Payables (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Change in Account Payables of -$2.7 million for Q1 2026, down 539.84% year-over-year from $615000.0 in Q1 2025, and down 180.87% quarter-over-quarter from $3.3 million in Q4 2025.
Rigel Pharmaceuticals (RIGL) Change in Account Payables (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Change in Account Payables history runs 17 years deep, the most recent figure standing at -$2.7 million for Q1 2026.
- In Q1 2026, Change in Account Payables fell 539.84% year-over-year to -$2.7 million; the TTM figure through Mar 2026 stood at $532000.0 (up 110.0% YoY), while the FY2025 annual figure was $3.9 million, up 201.29% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$2.7 million, down from $3.3 million in the prior quarter.
- The five-year high for Change in Account Payables was $4.8 million in Q4 2022, with the low at -$3.4 million in Q3 2025.
- The 5-year median for Change in Account Payables is -$476000.0 (2024), against an average of $45058.8.
- The sharpest annual moves came in 2025 and 2026: Change in Account Payables surged 802.73% in 2025, then plunged 539.84% in 2026.
- Rigel Pharmaceuticals' Change in Account Payables stood at $4.8 million in 2022, then tumbled by 117.9% to -$857000.0 in 2023, then surged by 44.46% to -$476000.0 in 2024, then soared by 802.73% to $3.3 million in 2025, then plunged by 180.87% to -$2.7 million in 2026.
- Business Quant data shows RIGL's Change in Account Payables at -$2.7 million in Q1 2026, $3.3 million in Q4 2025, and -$3.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn | -475,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -475,000.00 |
| Jun 30, 2026 | -475,000.00 |
| Mar 31, 2026 | -2.71 Mn |
| Mar 31, 2026 | -2.71 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Dec 31, 2025 | 3.35 Mn |
| Sep 30, 2025 | -3.44 Mn |
| Sep 30, 2025 | -3.44 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 615,000.00 |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Dec 31, 2024 | -476,000.00 |
| Sep 30, 2024 | -2.32 Mn |
| Sep 30, 2024 | -2.32 Mn |
| Jun 30, 2024 | -3.15 Mn |
| Jun 30, 2024 | -3.15 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Mar 31, 2024 | 2.13 Mn |